Sharifi N - Search Results

1

Through the Looking-Glass: Reevaluating DHEA Metabolism Through HSD3B1 Genetics.

Naelitz BD, Sharifi N. Naelitz BD, et al. Among authors: sharifi n. Trends Endocrinol Metab. 2020 Sep;31(9):680-690. doi: 10.1016/j.tem.2020.05.006. Epub 2020 Jun 18. Trends Endocrinol Metab. 2020. PMID: 32565196 Free PMC article. Review.

2

A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.

Chang KH, Li R, Kuri B, Lotan Y, Roehrborn CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, Mirzaei H, Auchus RJ, Sharifi N. Chang KH, et al. Among authors: sharifi n. Cell. 2013 Aug 29;154(5):1074-1084. doi: 10.1016/j.cell.2013.07.029. Cell. 2013. PMID: 23993097 Free PMC article.

3

Mechanisms of androgen receptor activation in castration-resistant prostate cancer.

Sharifi N. Sharifi N. Endocrinology. 2013 Nov;154(11):4010-7. doi: 10.1210/en.2013-1466. Epub 2013 Sep 3. Endocrinology. 2013. PMID: 24002034 Free PMC article. Review.

4

Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences.

Chang KH, Ercole CE, Sharifi N. Chang KH, et al. Among authors: sharifi n. Br J Cancer. 2014 Sep 23;111(7):1249-54. doi: 10.1038/bjc.2014.268. Epub 2014 May 27. Br J Cancer. 2014. PMID: 24867689 Free PMC article. Review.

5

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.

Li Z, Bishop AC, Alyamani M, Garcia JA, Dreicer R, Bunch D, Liu J, Upadhyay SK, Auchus RJ, Sharifi N. Li Z, et al. Among authors: sharifi n. Nature. 2015 Jul 16;523(7560):347-51. doi: 10.1038/nature14406. Epub 2015 Jun 1. Nature. 2015. PMID: 26030522 Free PMC article.

6

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.

Hearn JWD, AbuAli G, Reichard CA, Reddy CA, Magi-Galluzzi C, Chang KH, Carlson R, Rangel L, Reagan K, Davis BJ, Karnes RJ, Kohli M, Tindall D, Klein EA, Sharifi N. Hearn JWD, et al. Among authors: sharifi n. Lancet Oncol. 2016 Oct;17(10):1435-1444. doi: 10.1016/S1470-2045(16)30227-3. Epub 2016 Aug 27. Lancet Oncol. 2016. PMID: 27575027 Free PMC article.

7

Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities.

Alyamani M, Li Z, Berk M, Li J, Tang J, Upadhyay S, Auchus RJ, Sharifi N. Alyamani M, et al. Among authors: sharifi n. Cell Chem Biol. 2017 Jul 20;24(7):825-832.e6. doi: 10.1016/j.chembiol.2017.05.020. Epub 2017 Jun 22. Cell Chem Biol. 2017. PMID: 28648378 Free PMC article.

8

HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer.

Almassi N, Reichard C, Li J, Russell C, Perry J, Ryan CJ, Friedlander T, Sharifi N. Almassi N, et al. Among authors: sharifi n. JAMA Oncol. 2018 Apr 1;4(4):554-557. doi: 10.1001/jamaoncol.2017.3159. JAMA Oncol. 2018. PMID: 29049452 Free PMC article.

9

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.

Hearn JWD, Xie W, Nakabayashi M, Almassi N, Reichard CA, Pomerantz M, Kantoff PW, Sharifi N. Hearn JWD, et al. Among authors: sharifi n. JAMA Oncol. 2018 Apr 1;4(4):558-562. doi: 10.1001/jamaoncol.2017.3164. JAMA Oncol. 2018. PMID: 29049492 Free PMC article.

10

HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer.

Hettel D, Sharifi N. Hettel D, et al. Among authors: sharifi n. Nat Rev Urol. 2018 Mar;15(3):191-196. doi: 10.1038/nrurol.2017.201. Epub 2017 Dec 12. Nat Rev Urol. 2018. PMID: 29231195 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters